CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Open-market buy Director bought 2,000 shares at $3.19 ($6,380)
- 4 Open-market sale 10% owner sold 10,000 shares at $3.37 ($33,700)
- 4 Open-market buy Director bought 3,000 shares at $3.37 ($10,107)
- 4 Grant or award President and CEO acquired 4,946 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $3.62 ($36,200)
- 4 Grant or award President and CEO acquired 4,296 shares (grant or award)
- 4 Open-market buy Director bought 3,000 shares at $3.88 ($11,631)
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 4,468 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $3.91 ($39,100)
- 4 Grant or award President and CEO acquired 4,241 shares (grant or award)
- 4 Grant or award President and CEO acquired 4,931 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $3.25 ($32,500)
- 4 Grant or award President and CEO acquired 6,061 shares (grant or award)
- 4 Grant or award President and CEO acquired 6,435 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $3.54 ($35,400)
- 4 Grant or award President and CEO acquired 5,208 shares (grant or award)
- 4 Grant or award President and CEO acquired 4,762 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $3.91 ($39,100)
- 4 Grant or award President and CEO acquired 4,198 shares (grant or award)
Page 12 of 39 · 776 filings